High bioavailabilty of alpha-tocopherol loaded into poly (DL-lactic-co-glycolic acid) microspheres in apolipoprotein B knockout mice

Pharm Res. 2003 Nov;20(11):1846-50. doi: 10.1023/b:pham.0000003384.38161.ba.

Abstract

Purpose: To assess the potential clinical value of alpha-tocopherol-loaded poly (DL-lactic-co-glycolic acid) (PLGA) microspheres, we examined the disposition kinetics of alpha-tocopherol after administration of the microspheres to apolipoprotein B (apo B) knockout mice as a model of abetalipoproteinemia.

Methods: PLGA microspheres containing alpha-tocopherol were prepared by a solvent-evaporation method. The concentration of alpha-tocopherol was measured by gas chromatography-mass spectrometry.

Results: The mean value of particle size of alpha-tocopherol-loaded PLGA microspheres was 108 microm. The loading and the trapping efficiency of alpha-tocopherol in PLGA microspheres were 20.8% and 86.6%, respectively. When alpha-tocopherol solution (25 mg/kg) was subcutaneously administered to apob (+/+) and apob (+/-) mice, the plasma concentrations of alpha-tocopherol reached a peak at 6 h and decreased to the endogenous level within 4 days in both types of mice. However, the area under the plasma concentration-time curve (AUC) of apob (+/-) mice was significantly smaller than that in the case of apob (+/+) mice. When alpha-tocopherol-loaded PLGA microspheres (100 mg/kg) were subcutaneously administered, the plasma concentrations of alpha-tocopherol increased slowly and remained about 2-fold higher than the endogenous level at 5 to 10 days after administration in both types of mice, and there was no significant difference between the AUC values.

Conclusions: The PLGA microsphere preparation of alpha-tocopherol is expected to be a very useful drug delivery system in vitamin E supplementation therapy for abetalipoproteinemia.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Biological Availability
  • Female
  • Injections, Subcutaneous
  • Lactic Acid / administration & dosage
  • Lactic Acid / pharmacokinetics*
  • Liver / metabolism
  • Male
  • Mice
  • Mice, Knockout
  • Microspheres*
  • Polyglycolic Acid / administration & dosage
  • Polyglycolic Acid / pharmacokinetics*
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polymers / administration & dosage
  • Polymers / pharmacokinetics*
  • Receptors, Lipoprotein / deficiency*
  • Receptors, Lipoprotein / genetics*
  • Tissue Distribution / genetics
  • alpha-Tocopherol / administration & dosage
  • alpha-Tocopherol / blood
  • alpha-Tocopherol / pharmacokinetics*

Substances

  • Polymers
  • Receptors, Lipoprotein
  • apolipoprotein B receptor
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polyglycolic Acid
  • Lactic Acid
  • alpha-Tocopherol